Obicetrapib hemicalcium
Based on 1 publication(s) in Google Scholar
Obicetrapib hemicalcium (TA-8995; DEZ-001) is an orally active cholesteryl ester transfer protein (CETP) inhibitor. Obicetrapib hemicalcium potently reduces atherogenic lipoproteins (such as LDL-C, ApoB, Lp (a)) and increases HDL-C. Obicetrapib hemicalcium can be used for the research of dyslipidemia and atherosclerotic cardiovascular disease (ASCVD).
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 866399-89-5
- Formule: C32H31F9N4O5·1/2Ca
- Masse moléculaire:742.65
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
- Protocole
- Pureté et documentation
- Références
-
Help & FAQs
Publications Citing Use of MedChemExpress (MCE) Obicetrapib hemicalcium
More
Activité biologique
Description
|
apoB |
CETP |
In Vitro
Chemical Information
-
CAS No. 866399-89-5
-
Masse moléculaire 742.65
-
Formule C32H31F9N4O5·1/2Ca
-
SMILES
FC(F)(F)C1=CC(C(F)(F)F)=CC(CN(C2=NC=C(OCCCC(O)=O)C=N2)[C@@H]3C4=CC(C(F)(F)F)=CC=C4N([C@@H](C3)CC)C(OCC)=O)=C1.[Ca].[1/2]
-
Synonyms
TA-8995 hemicalcium; DEZ-001 hemicalcium; AMG-899 hemicalcium
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (1)
-
Journal Impact Factor
-
Most Recent
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Obicetrapib hemicalcium Related Classifications
HY-18778C Related Classifications
Powered by Bioz
Keywords
- Obicetrapib hemicalcium
- 866399-89-5
- TA-8995 hemicalcium
- DEZ-001 hemicalcium
- AMG-899 hemicalcium
- CETP
- Apolipoprotein
- LPL Receptor
- LDLR
- very low-density lipoprotein
- high-density lipoprotein
- dyslipidemia
- low-density lipoprotein
- apolipoprotein B
- cholesteryl esters
- cholesteryl ester transfer protein
- atherosclerotic cardiovascular disease
- triglycerides
- Inhibitor
- inhibitor
- inhibit